This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medigene, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Ian Richard Mathews: Innovator in Immunomodulation
Introduction
Ian Richard Mathews is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunomodulation through his innovative research and development of novel compounds. His work focuses on addressing various autoimmune diseases and conditions.
Latest Patents
Ian Richard Mathews holds a patent for "Immuno inhibitory heterocyclic compounds." This patent describes compounds that act as CD80 inhibitors, which are valuable for immunomodulation in conditions such as rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosus, and psoriasis. The compounds are characterized by specific formulas and functional groups that enhance their efficacy in therapeutic applications.
Career Highlights
Ian is currently associated with Medigene, Inc., where he continues to advance his research in immunology and drug development. His expertise in creating innovative solutions for complex health issues has positioned him as a key figure in the biotechnology sector.
Conclusion
Ian Richard Mathews exemplifies the spirit of innovation in the field of immunomodulation. His contributions through patents and research are paving the way for new treatments that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile